JNJ

171.13

+2.32%↑

NVS

117.8

+2.37%↑

ABT

130.11

+2.14%↑

TMO

467.4

+1%↑

ISRG

483.15

-0.03%↓

JNJ

171.13

+2.32%↑

NVS

117.8

+2.37%↑

ABT

130.11

+2.14%↑

TMO

467.4

+1%↑

ISRG

483.15

-0.03%↓

JNJ

171.13

+2.32%↑

NVS

117.8

+2.37%↑

ABT

130.11

+2.14%↑

TMO

467.4

+1%↑

ISRG

483.15

-0.03%↓

JNJ

171.13

+2.32%↑

NVS

117.8

+2.37%↑

ABT

130.11

+2.14%↑

TMO

467.4

+1%↑

ISRG

483.15

-0.03%↓

JNJ

171.13

+2.32%↑

NVS

117.8

+2.37%↑

ABT

130.11

+2.14%↑

TMO

467.4

+1%↑

ISRG

483.15

-0.03%↓

Search

Exact Sciences Corp

Closed

SectorHealthcare

46.82 -2.17

Overview

Share price change

24h

Current

Min

46.14

Max

47.86

Key metrics

By Trading Economics

Income

763M

-101M

Sales

-6.6M

707M

Profit margin

-14.32

Employees

6,900

EBITDA

719M

-96M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+43.78% upside

Dividends

By Dow Jones

Next Earnings

6 Aug 2025

Market Stats

By TradingEconomics

Market Cap

-305M

9.1B

Previous open

48.99

Previous close

46.82

News Sentiment

By Acuity

50%

50%

175 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Exact Sciences Corp Chart

Past performance is not a reliable indicator of future results.

Related News

6 Nov 2024, 10:24 UTC

Earnings

These Stocks Are Moving the Most Today: Trump Media, Tesla, First Solar, Coinbase, Super Micro, Nvidia, Exact Sciences, and More -- Barrons.com

Peer Comparison

Price change

Exact Sciences Corp Forecast

Price Target

By TipRanks

43.78% upside

12 Months Forecast

Average 68.67 USD  43.78%

High 75 USD

Low 54 USD

Based on 13 Wall Street analysts offering 12 month price targets forExact Sciences Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

11

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

45.6 / 54.37Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

175 / 374 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Exact Sciences Corp

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.